428 related articles for article (PubMed ID: 21724842)
1. Deep sequencing reveals distinct patterns of DNA methylation in prostate cancer.
Kim JH; Dhanasekaran SM; Prensner JR; Cao X; Robinson D; Kalyana-Sundaram S; Huang C; Shankar S; Jing X; Iyer M; Hu M; Sam L; Grasso C; Maher CA; Palanisamy N; Mehra R; Kominsky HD; Siddiqui J; Yu J; Qin ZS; Chinnaiyan AM
Genome Res; 2011 Jul; 21(7):1028-41. PubMed ID: 21724842
[TBL] [Abstract][Full Text] [Related]
2. Methylation profiling identified novel differentially methylated markers including OPCML and FLRT2 in prostate cancer.
Wu Y; Davison J; Qu X; Morrissey C; Storer B; Brown L; Vessella R; Nelson P; Fang M
Epigenetics; 2016 Apr; 11(4):247-58. PubMed ID: 26890304
[TBL] [Abstract][Full Text] [Related]
3. Promoter CpG-Site Methylation of the KAI1 Metastasis Suppressor Gene Contributes to Its Epigenetic Repression in Prostate Cancer.
Lee J; Lee MS; Jeoung DI; Kim YM; Lee H
Prostate; 2017 Mar; 77(4):350-360. PubMed ID: 27813113
[TBL] [Abstract][Full Text] [Related]
4. Epigenomic profiling of DNA methylation in paired prostate cancer versus adjacent benign tissue.
Geybels MS; Zhao S; Wong CJ; Bibikova M; Klotzle B; Wu M; Ostrander EA; Fan JB; Feng Z; Stanford JL
Prostate; 2015 Dec; 75(16):1941-50. PubMed ID: 26383847
[TBL] [Abstract][Full Text] [Related]
5. Tumor suppressor function of PGP9.5 is associated with epigenetic regulation in prostate cancer--novel predictor of biochemical recurrence after radical surgery.
Mitsui Y; Shiina H; Hiraki M; Arichi N; Hiraoka T; Sumura M; Honda S; Yasumoto H; Igawa M
Cancer Epidemiol Biomarkers Prev; 2012 Mar; 21(3):487-96. PubMed ID: 22246902
[TBL] [Abstract][Full Text] [Related]
6. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
Kelavkar UP; Harya NS; Hutzley J; Bacich DJ; Monzon FA; Chandran U; Dhir R; O'Keefe DS
Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):185-97. PubMed ID: 17164146
[TBL] [Abstract][Full Text] [Related]
7. Altered DNA methylation landscapes of polycomb-repressed loci are associated with prostate cancer progression and ERG oncogene expression in prostate cancer.
Kron K; Trudel D; Pethe V; Briollais L; Fleshner N; van der Kwast T; Bapat B
Clin Cancer Res; 2013 Jul; 19(13):3450-61. PubMed ID: 23549870
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic regulation of the ITGB4 gene in prostate cancer.
Wilkinson EJ; Woodworth AM; Parker M; Phillips JL; Malley RC; Dickinson JL; Holloway AF
Exp Cell Res; 2020 Jul; 392(2):112055. PubMed ID: 32376286
[TBL] [Abstract][Full Text] [Related]
9. Survey of differentially methylated promoters in prostate cancer cell lines.
Wang Y; Yu Q; Cho AH; Rondeau G; Welsh J; Adamson E; Mercola D; McClelland M
Neoplasia; 2005 Aug; 7(8):748-60. PubMed ID: 16207477
[TBL] [Abstract][Full Text] [Related]
10. DNA methylation profiling reveals novel biomarkers and important roles for DNA methyltransferases in prostate cancer.
Kobayashi Y; Absher DM; Gulzar ZG; Young SR; McKenney JK; Peehl DM; Brooks JD; Myers RM; Sherlock G
Genome Res; 2011 Jul; 21(7):1017-27. PubMed ID: 21521786
[TBL] [Abstract][Full Text] [Related]
11. Identification of CpG Sites of
Hagelgans A; Jandeck C; Friedemann M; Donchin A; Richter S; Menschikowski M
Anticancer Res; 2017 Dec; 37(12):6609-6618. PubMed ID: 29187436
[TBL] [Abstract][Full Text] [Related]
12. The presence of RNA polymerase II, active or stalled, predicts epigenetic fate of promoter CpG islands.
Takeshima H; Yamashita S; Shimazu T; Niwa T; Ushijima T
Genome Res; 2009 Nov; 19(11):1974-82. PubMed ID: 19652013
[TBL] [Abstract][Full Text] [Related]
13. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.
Pulukuri SM; Rao JS
Oncogene; 2006 Aug; 25(33):4559-72. PubMed ID: 16786000
[TBL] [Abstract][Full Text] [Related]
14. Effects of sulforaphane and 3,3'-diindolylmethane on genome-wide promoter methylation in normal prostate epithelial cells and prostate cancer cells.
Wong CP; Hsu A; Buchanan A; Palomera-Sanchez Z; Beaver LM; Houseman EA; Williams DE; Dashwood RH; Ho E
PLoS One; 2014; 9(1):e86787. PubMed ID: 24466240
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide DNA methylome analysis reveals epigenetically dysregulated non-coding RNAs in human breast cancer.
Li Y; Zhang Y; Li S; Lu J; Chen J; Wang Y; Li Y; Xu J; Li X
Sci Rep; 2015 Mar; 5():8790. PubMed ID: 25739977
[TBL] [Abstract][Full Text] [Related]
16. Cell type-specific DNA methylation at intragenic CpG islands in the immune system.
Deaton AM; Webb S; Kerr AR; Illingworth RS; Guy J; Andrews R; Bird A
Genome Res; 2011 Jul; 21(7):1074-86. PubMed ID: 21628449
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide DNA methylation profiling using Infinium® assay.
Bibikova M; Le J; Barnes B; Saedinia-Melnyk S; Zhou L; Shen R; Gunderson KL
Epigenomics; 2009 Oct; 1(1):177-200. PubMed ID: 22122642
[TBL] [Abstract][Full Text] [Related]
18. Functional role and tobacco smoking effects on methylation of CYP1A1 gene in prostate cancer.
Mitsui Y; Chang I; Kato T; Hashimoto Y; Yamamura S; Fukuhara S; Wong DK; Shiina M; Imai-Sumida M; Majid S; Saini S; Shiina H; Nakajima K; Deng G; Dahiya R; Tanaka Y
Oncotarget; 2016 Aug; 7(31):49107-49121. PubMed ID: 27203547
[TBL] [Abstract][Full Text] [Related]
19. DNA Methylation-Mediated Downregulation of DEFB1 in Prostate Cancer Cells.
Lee J; Han JH; Jang A; Kim JW; Hong SA; Myung SC
PLoS One; 2016; 11(11):e0166664. PubMed ID: 27835705
[TBL] [Abstract][Full Text] [Related]
20. Methylation and inactivation of estrogen, progesterone, and androgen receptors in prostate cancer.
Sasaki M; Tanaka Y; Perinchery G; Dharia A; Kotcherguina I; Fujimoto Si; Dahiya R
J Natl Cancer Inst; 2002 Mar; 94(5):384-90. PubMed ID: 11880477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
